Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

CKD stock price, quote, forecast and news

6407.T
JP3346800000

Price

2,606.00
Today +/-
-0.46
Today %
-2.76 %
P

CKD stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the CKD stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the CKD stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the CKD stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze CKD's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

CKD Stock Price History

DateCKD Price
9/6/20242,606.00 undefined
9/5/20242,679.00 undefined
9/4/20242,746.00 undefined
9/3/20242,977.00 undefined
9/2/20242,978.00 undefined
8/30/20242,932.00 undefined
8/29/20242,871.00 undefined
8/28/20242,836.00 undefined
8/27/20242,848.00 undefined
8/26/20242,853.00 undefined
8/23/20242,944.00 undefined
8/22/20242,997.00 undefined
8/21/20242,992.00 undefined
8/20/20243,070.00 undefined
8/19/20243,055.00 undefined
8/16/20243,185.00 undefined
8/15/20243,005.00 undefined
8/14/20242,987.00 undefined
8/13/20242,988.00 undefined
8/9/20242,666.00 undefined

CKD Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into CKD, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by CKD from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects CKD’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of CKD. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into CKD’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing CKD’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on CKD’s growth potential.

CKD Revenue, EBIT and net profit per share

DateCKD RevenueCKD EBITCKD Net Income
2027e184.93 B undefined0 undefined19.91 B undefined
2026e172.26 B undefined0 undefined17.24 B undefined
2025e152.79 B undefined0 undefined12.96 B undefined
2024134.43 B undefined13.11 B undefined8.34 B undefined
2023159.46 B undefined21.17 B undefined14.79 B undefined
2022142.2 B undefined17.88 B undefined12.57 B undefined
2021106.72 B undefined7.7 B undefined5.27 B undefined
2020100.72 B undefined5.23 B undefined3.69 B undefined
2019115.67 B undefined5.43 B undefined4.79 B undefined
2018115.7 B undefined12.47 B undefined9.14 B undefined
201794.01 B undefined9.58 B undefined6.96 B undefined
201688.12 B undefined8.11 B undefined5.46 B undefined
201583.38 B undefined8.36 B undefined6.01 B undefined
201475.49 B undefined7.88 B undefined5.46 B undefined
201365.03 B undefined3.24 B undefined2.45 B undefined
201272.8 B undefined6.07 B undefined3.74 B undefined
201172.02 B undefined7.51 B undefined4.58 B undefined
201050.04 B undefined339 M undefined1.49 B undefined
200968.18 B undefined1.43 B undefined-2.85 B undefined
200893.71 B undefined9.49 B undefined5.55 B undefined
2007104.26 B undefined12.72 B undefined7.54 B undefined
200684.31 B undefined8.96 B undefined5.18 B undefined
200577.2 B undefined7.71 B undefined3.92 B undefined

CKD Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
83.5288.2871.2876.1493.0359.1358.1165.8977.284.31104.2693.7168.1850.0472.0272.865.0375.4983.3888.1294.01115.7115.67100.72106.72142.2159.46134.43152.79172.26184.93
-5.70-19.256.8122.19-36.44-1.7213.3717.189.2123.66-10.13-27.25-26.6143.941.09-10.6816.0810.455.686.6923.07-0.03-12.925.9633.2412.14-15.7013.6612.757.35
26.6926.1924.2925.1427.4325.2526.5728.1829.6628.3527.9126.9222.5822.8328.6827.0026.1830.6730.5130.3430.5630.9724.6525.9526.9628.7629.1028.30---
22.2923.1217.3119.1425.5214.9315.4418.5722.923.929.125.2215.3911.4220.6619.6617.0223.1525.4426.7428.7335.8428.5126.1428.7740.8946.438.04000
3.373.43-0.052.377.211.332.014.467.718.9612.729.491.430.347.516.073.247.888.368.119.5812.475.435.237.717.8821.1713.11000
4.043.89-0.063.127.752.253.466.779.9810.6212.2010.132.090.6810.438.334.9910.4410.039.2010.1910.784.695.197.2112.5713.289.75---
1.040.58-1.64-5.663.071.292.611.863.925.187.545.55-2.851.494.583.742.455.466.015.466.969.144.793.695.2712.5714.798.3412.9617.2419.91
--44.13-381.58246.21-154.18-58.06103.03-28.82110.7532.1945.52-26.42-151.34-152.44206.36-18.27-34.46122.5110.15-9.1727.4631.39-47.57-23.0342.94138.3317.67-43.6255.4333.0215.48
-------------------------------
-------------------------------
67666464706968656771686663626263636262.4562.0561.9261.9261.9261.9565.7466.6466.6966.74000
-------------------------------
Details

Keystats

Revenue and Growth

The CKD Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the CKD is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (B)EQUITY (B)LIABILITIES (B)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                       
6.756.558.047.074.414.565.384.158.83.664.473.614.525.687.856.0610.3213.9815.2511.9514.3415.2512.4618.9936.3834.5328.5728.3
31.2429.8823.6427.9337.3419.818.0723.2822.2828.0729.2722.8115.9918.7122.3621.918.5822.2323.3624.1427.6232.0828.12927.830.5632.2331.6
0.710.8500000.950.44000000000000000004.294.442.03
13.6315.3113.8113.8313.1311.611.0111.7311.8414.4217.8616.5914.212.9116.616.8516.1816.619.320.5223.9534.7239.8735.9736.3344.7655.3860.04
0.320.331.582.321.611.922.341.712.362.562.572.142.191.741.992.062.53.932.592.362.981.693.011.461.292.052.442.35
52.6552.9247.0751.1456.537.8937.7541.345.2748.7154.1645.1536.939.0448.846.8647.5856.7460.5158.9768.8883.7383.4585.42101.79116.19123.06124.33
23.2325.2323.724.0921.0719.6117.7516.9417.9817.7424.4823.4621.4619.2318.6317.9818.3422.7324.8527.7127.0633.242.6440.2338.9944.0249.3365.69
1.791.181.421.411.651.841.391.641.632.675.623.892.723.623.833.713.935.235.237.867.2806.156.038.188.138.5111.5
7975224107633319600000000000000000000
0.10.10.120.260.230.220.180.260.340.50.630.540.440.330.260.820.820.750.820.761.762.612.381.871.431.111.521.63
3.764.053.422.930.030.020.02000000000000000000000
2.962.13.218.334.835.764.083.242.742.091.72.161.280.630.640.711.061.272.931.111.3811.352.352.512.333.073.215.15
31.9232.7332.0937.1427.8627.4923.4522.0922.692332.4330.0525.923.8223.3723.2224.1629.9733.8337.4437.4847.1653.5150.6450.9456.3362.5783.96
84.5685.6579.1688.2884.3665.3861.263.3967.9671.7186.5975.262.862.8672.1670.0871.7486.7194.3396.41106.36130.89136.96136.06152.73172.51185.63208.29
                                                       
8.898.948.948.948.948.948.948.948.9410.3610.411.0211.0211.0211.0211.0211.0211.0211.0211.0211.0211.0211.0211.0211.0211.0211.0211.02
9.689.739.739.739.739.739.739.7310.5411.961212.6112.6112.6112.7412.7412.7412.7412.7412.3712.3712.3812.3912.0216.3616.3616.5516.63
5.825.773.51.173.994.616.677.9311.3615.6321.9825.8721.6622.6626.6729.5231.2735.9140.6144.4549.7256.8159.1262.0665.9275.4484.8188.39
0000-0.27-0.08-0.2-0.45-0.260.080.350.43-0.39-0.33-0.63-0.740.041.413.30.390.10.790.57-0.681.714.344.718.38
000000.080.030.370.410.771.01-0.32-0.360.470.580.50.621.252.4502.653.862.121.93.393.273.495.5
24.3924.4522.1719.8522.423.2825.1726.5230.9938.845.7349.6144.5346.4250.3853.0355.6862.3270.1168.2275.8684.8685.2186.3198.39110.44120.56129.9
14.4615.2810.1214.1115.87.8410.097.691014.6715.5213.586.779.6211.039.348.0410.4912.3712.7916.1621.4515.0115.3618.1924.7427.3719.68
3.193.372.793.093.022.072.453.012.853.183.182.551.821.822.362.222.042.642.912.853.270.413.413.453.865.245.344.32
8.65.432.293.865.711.82.445.776.76.2914.044.331.882.165.934.563.779.495.946.278.814.567.058.949.6711.5410.5211.5
11.6511.7314.129.57.824.392.944.341.10.791.986.277.523.312.852.021.791.551.150.90.886.598.216.096.165.676.065.91
2005.982.254.942.790.288.840.310.011.311.150.80.770.721.170.570.80.830.540.063.663.923.756.332.731.58
39.935.8229.3336.5334.621.0320.721.129.4925.2434.7328.0419.1417.7122.9418.8616.824.7323.1723.6529.6543.0737.3337.7641.6453.552.0242.99
15.4920.8223.0817.6116.4611.529.4710.461.622.982.90.372.852.12.361.362.221.413.52.822.315.0416.8413.510.55.99.8430.05
0.570.560.720.4100.010.010000000.070.250.340.571.051.051.811.6300.10.130.640.851.253.35
3.533.413.2113.0410.599.527.227.566.525.4541.31.211.511.281.21.31.811.541.721.832.722.252.22.342.692.792.81
19.5924.7827.0231.0627.0521.0616.6918.038.148.436.91.674.063.673.892.94.094.276.096.345.767.7619.1915.8313.479.4413.8836.2
59.4960.656.3467.5961.6542.0937.439.1337.6333.6741.6229.7123.221.3826.8321.7620.892929.2629.9935.450.8356.5253.5955.1162.9465.979.19
83.8885.0478.5187.4384.0565.3762.5765.6568.6272.4687.3579.3167.7367.877.274.7976.5791.3299.3798.21111.27135.69141.73139.91153.5173.38186.46209.09
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of CKD provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand CKD's financial health and stability.

Assets

CKD's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that CKD must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of CKD after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into CKD's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-8.655.631.023.573.566.948.8512.559.51-1.10.827.36.213.58.388.788.099.9212.845.855.247.7317.9521.39
3.673.482.812.352.122.032.242.653.573.312.922.642.772.622.493.194.063.964.235.175.825.515.916.63
000000000000000000000000
-0.19-3.051.324.87-4.58-0.91-6.45-6.09-1.63-1.543.12-6.04-4.931.45-1.63-5.82-4.15-3.98-11.8-10.914.074.13-12.44-16.97
10.78-0.31-0.7-1.720.57-0.49-0.7-1.4-1.331.530.910.14-0.28-0.560.520.090.020.250.28-2.362.120.160.940.01
79067744328222016913393116133112777673664448397199223207224311
0.362.31.470.180.210.633.993.15.471.71-1.220.724.131.460.093.981.782.583.963.93-0.131.723.066.52
5.615.764.469.061.677.573.947.7110.112.27.774.043.777.019.756.238.0310.165.54-2.2517.2517.5212.3511.05
-2,086-2,371-3,522-754-1,386-2,076-3,571-3,709-8,585-2,160-917-1,001-3,231-2,990-3,847-6,044-7,556-5,242-8,128-16,310-4,081-2,958-8,237-11,751
-1.92-3.32.4-0.83-0.81-1.75-3.53-6.6-10.32-2.28-0.83-1.05-3.02-5.02-6.22-4.76-6.18-4.08-7.27-14.87-4.56-2.79-8.54-12.79
0.16-0.935.92-0.080.570.330.05-2.89-1.73-0.120.09-0.050.21-2.03-2.381.291.371.160.861.44-0.470.17-0.31-1.04
000000000000000000000000
-3.97-4.5-5.82-5.55-0.43-3.12-4.780.784.213.57-5.3-0.14-1.750.91-1.731.92-0.96-0.774.716.92-5.42-3.3-30.02
00-0.36-1.17-0.92.55-0.06-0.02-3.34-0.8200.030.26-0.240.260.06-0.70-000.437.31-00
-4.57-5.08-6.84-7.35-1.88-1.23-5.65-0.39-0.81.32-5.84-0.77-2.45-0.06-2.330.62-3.33-2.512.5614.37-6.022.42-6.26-5.74
-12-7-83-61-14-16-225-15-39-42-96-70-32-50-51-54-61-100-71-230-251-272-369
-580-580-580-570-532-633-815-1,187-1,653-1,391-499-558-886-692-810-1,309-1,614-1,672-2,038-2,473-805-1,340-2,995-5,393
-0.94-2.610.150.81-1.234.61-5.090.81-0.850.851.122.15-1.772.221.652.46-1.953.560.89-2.776.3817.5-1.89-7.37
3,5243,3889338,3102835,4963704,0041,529406,8563,0425434,0175,9071834704,919-2,585-18,56413,16714,5644,116-702
000000000000000000000000

CKD stock margins

The CKD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CKD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CKD.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the CKD's sales revenue. A higher gross margin percentage indicates that the CKD retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the CKD's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the CKD's total revenue generated. When comparing the revenue margin year over year, investors can gauge the CKD's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the CKD. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the CKD's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

CKD Margin History

CKD Gross marginCKD Profit marginCKD EBIT marginCKD Profit margin
2027e28.3 %0 %10.77 %
2026e28.3 %0 %10.01 %
2025e28.3 %0 %8.48 %
202428.3 %9.75 %6.2 %
202329.1 %13.28 %9.27 %
202228.76 %12.57 %8.84 %
202126.96 %7.21 %4.94 %
202025.95 %5.19 %3.66 %
201924.65 %4.69 %4.14 %
201830.97 %10.78 %7.9 %
201730.56 %10.19 %7.4 %
201630.34 %9.2 %6.2 %
201530.51 %10.03 %7.21 %
201430.67 %10.44 %7.23 %
201326.18 %4.99 %3.77 %
201227 %8.33 %5.14 %
201128.68 %10.43 %6.36 %
201022.83 %0.68 %2.99 %
200922.58 %2.09 %-4.18 %
200826.92 %10.13 %5.92 %
200727.91 %12.2 %7.23 %
200628.35 %10.62 %6.15 %
200529.66 %9.98 %5.08 %

CKD Stock Sales Revenue, EBIT, Earnings per Share

The CKD earnings per share therefore indicates how much revenue CKD has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue CKD earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates CKD's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of CKD’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating CKD's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

CKD Revenue, EBIT and net profit per share

DateCKD Sales per ShareCKD EBIT per shareCKD Earnings per Share
2027e2,754.57 undefined0 undefined296.54 undefined
2026e2,565.86 undefined0 undefined256.78 undefined
2025e2,275.81 undefined0 undefined193.04 undefined
20242,014.31 undefined196.49 undefined124.94 undefined
20232,391.05 undefined317.44 undefined221.75 undefined
20222,133.74 undefined268.28 undefined188.57 undefined
20211,623.44 undefined117.1 undefined80.21 undefined
20201,625.67 undefined84.42 undefined59.54 undefined
20191,868.04 undefined87.68 undefined77.41 undefined
20181,868.66 undefined201.43 undefined147.65 undefined
20171,518.38 undefined154.73 undefined112.38 undefined
20161,420.21 undefined130.66 undefined87.98 undefined
20151,335.09 undefined133.91 undefined96.23 undefined
20141,217.6 undefined127.15 undefined88 undefined
20131,032.24 undefined51.49 undefined38.92 undefined
20121,155.62 undefined96.3 undefined59.38 undefined
20111,161.61 undefined121.11 undefined73.82 undefined
2010807.02 undefined5.47 undefined24.1 undefined
20091,082.14 undefined22.62 undefined-45.22 undefined
20081,419.77 undefined143.76 undefined84.08 undefined
20071,533.26 undefined187.06 undefined110.9 undefined
20061,187.49 undefined126.17 undefined72.99 undefined
20051,152.3 undefined115.01 undefined58.51 undefined

CKD business model

The CKD Corporation is a Japanese company based in Kitakyushu, Japan. It was founded in 1943 and has since grown into a globally operating corporation in the fields of automation technology, mechanical engineering, and products for industrial applications. CKD has a long history of manufacturing products for the automation industry, starting with components for pneumatic systems and expanding to include hydraulic, electric, and electronic products. The company offers a wide range of products and solutions for automation tasks, including sensors, control systems, drives, and valves. CKD operates in various industries, including automotive, electronics, mechanical engineering, and aviation, with subsidiaries in countries such as the USA, China, Taiwan, Singapore, Malaysia, and Thailand. Important business areas for CKD include the production of pneumatic components, systems, and equipment, as well as semiconductor manufacturing machines. The company also produces systems for use in airplanes, such as pressure regulators. In summary, CKD Corporation is a globally operating company with a wide range of products and a strong presence in various industries. It specializes in automation technology and provides products and solutions for industrial applications, particularly in the areas of pneumatics, semiconductor manufacturing, and aviation. CKD holds a strong position in all of these industries and is an important supplier of products and systems. CKD is one of the most popular companies on Eulerpool.com.

CKD SWOT Analysis

Strengths

CKD Corp has a strong brand reputation in the industry, with a long-standing history and a large customer base. The company consistently delivers high-quality products and services to its clients, which has contributed to its success. CKD Corp also boasts a highly skilled and experienced workforce, enabling them to provide innovative solutions and stay ahead of the competition. Moreover, the company has a well-established distribution network, ensuring wide market coverage and easy access to customers.

Weaknesses

One of the main weaknesses of CKD Corp is its heavy reliance on a few key customers for a significant portion of its revenue. This dependency poses a risk to the company's financial stability, especially in cases where these customers may reduce their orders or switch to competitors. Additionally, CKD Corp may face challenges in adapting to rapidly changing market trends and technologies, potentially impacting its ability to stay competitive in the long run.

Opportunities

There are several opportunities that CKD Corp can explore to drive growth and expand its market presence. The increasing global demand for its products and services offers the company an opportunity to enter new markets and reach a wider customer base. CKD Corp can also leverage emerging technologies, such as automation and artificial intelligence, to enhance its product offerings and improve operational efficiency. Moreover, strategic partnerships or acquisitions could provide access to complementary capabilities or new markets, further strengthening CKD Corp's position.

Threats

CKD Corp is exposed to various external threats that could impact its business operations. Intense competition within the industry, both from established players and emerging startups, poses a threat to CKD Corp's market share and profitability. Economic downturns or fluctuations in the global economy could also lead to a decrease in demand for CKD Corp's products, affecting its revenue. Finally, changing government regulations and policies, particularly regarding trade or environmental standards, could require CKD Corp to make significant adaptations to its operations.

CKD Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

CKD historical P/E ratio, EBIT, and P/S ratio.

CKD shares outstanding

The number of shares was CKD in 2023 — This indicates how many shares 66.689 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue CKD earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates CKD's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of CKD’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating CKD's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

CKD dividend history and estimates

In 2023, CKD paid a dividend amounting to 71 JPY. Dividend means that CKD distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for CKD provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify CKD’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating CKD's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

CKD Dividend History

DateCKD Dividend
2027e59.44 undefined
2026e59.47 undefined
2025e59.52 undefined
202456 undefined
202371 undefined
202281 undefined
202145 undefined
202021 undefined
201913 undefined
201840 undefined
201733 undefined
201627 undefined
201526 undefined
201421 undefined
201313 undefined
201211 undefined
201114 undefined
20109 undefined
20098 undefined
200822 undefined
200725 undefined
200618 undefined
200513 undefined

CKD dividend payout ratio

In 2023, CKD had a payout ratio of 44.77%. The payout ratio indicates the percentage of the company's profits that CKD distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for CKD represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for CKD could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate CKD's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

CKD Payout Ratio History

DateCKD Payout ratio
2027e46.38 %
2026e45.98 %
2025e45.22 %
202447.94 %
202344.77 %
202242.95 %
202156.1 %
202035.27 %
201916.79 %
201827.09 %
201729.37 %
201630.69 %
201527.02 %
201423.86 %
201333.4 %
201218.52 %
201118.97 %
201037.36 %
2009-17.69 %
200826.17 %
200722.54 %
200624.66 %
200522.22 %
Unfortunately, there are currently no price targets and forecasts available for CKD.

CKD latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/202430.3 45.87  (51.39 %)2025 Q1
3/31/202434.39 29.35  (-14.66 %)2024 Q4
12/31/202329.91 36.23  (21.13 %)2024 Q3
9/30/202331.86 31.3  (-1.74 %)2024 Q2
6/30/202341.64 28.06  (-32.62 %)2024 Q1
3/31/202352.55 53.37  (1.57 %)2023 Q4
12/31/202254.68 62.83  (14.9 %)2023 Q3
9/30/202253.09 58.57  (10.33 %)2023 Q2
6/30/202250.53 46.99  (-7.01 %)2023 Q1
3/31/202249.23 50.46  (2.49 %)2022 Q4
1
2
3
4

CKD list of shareholders

%
Name
Stocks
Change
Date
7.55 % Artisan Partners Limited Partnership5,068,300-901,1003/15/2024
7.02 % Nomura Asset Management Co., Ltd.4,716,000819,0008/31/2023
4.28 % CKD Corporation Employees2,872,00037,0009/30/2023
2.85 % Sumitomo Life Insurance Co.1,914,00009/30/2023
2.64 % CKD Corporation Friendships1,771,00034,0009/30/2023
2.46 % The Vanguard Group, Inc.1,654,0362,6003/31/2024
2.35 % Sumitomo Mitsui Banking Corp1,581,00009/30/2023
2.09 % The Dai-ichi Life Insurance Company, Limited1,400,00009/30/2023
1.38 % Ono Pharmaceutical Co Ltd925,00003/31/2023
1.37 % Okuma Corp922,80003/31/2023
1
2
3
4
5
...
10

CKD Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,930,740,670,780,540,60
SupplierCustomer0,850,600,62-0,07-0,280,24
SupplierCustomer0,82-0,02-0,02-0,77-0,710,22
SupplierCustomer0,810,800,760,900,860,41
SupplierCustomer0,760,970,660,890,560,50
SupplierCustomer0,720,690,280,52-0,250,15
SupplierCustomer0,650,780,830,910,53-
SupplierCustomer0,630,87-0,36-0,430,440,44
SupplierCustomer0,52-0,150,740,470,24-
SupplierCustomer0,160,560,860,920,770,71
1
2

Most common questions regarding CKD

What values and corporate philosophy does CKD represent?

CKD Corp is a renowned company representing strong values and a clear corporate philosophy. With a commitment to excellence, innovation, and customer satisfaction, CKD Corp believes in delivering high-quality products and services. The company emphasizes integrity, partnership, and sustainability in every aspect of its operations. CKD Corp strives to create long-term value for its stakeholders while fostering a culture of inclusivity and diversity. By prioritizing customer-centricity and fostering continuous improvement, CKD Corp establishes itself as a trusted and forward-thinking leader in the industry.

In which countries and regions is CKD primarily present?

CKD Corp is primarily present in Japan and Asia.

What significant milestones has the company CKD achieved?

Since its inception, CKD Corp has consistently achieved various significant milestones in its journey. Over the years, the company has successfully expanded its product range and strengthened its market presence. Noteworthy achievements include the introduction of innovative technologies, development of cutting-edge solutions, and strategic partnerships with key industry players. Additionally, CKD Corp has demonstrated exceptional growth in revenues and market share. Through its unwavering commitment to excellence and continuous improvement, CKD Corp has solidified its position as a leader in the industry.

What is the history and background of the company CKD?

CKD Corp, founded in 1943, is a leading Japanese company in the manufacturing and distribution of automation technology and equipment. With a rich history spanning over 75 years, CKD Corp has been a pioneer in developing innovative solutions to meet the evolving needs of various industries. The company excels in producing pneumatic components, control equipment, and fluid control systems, serving sectors such as automotive, electronics, and food processing. CKD Corp's commitment to quality, reliability, and customer satisfaction has enabled them to establish a strong presence in both domestic and international markets. Continuously adapting to technological advancements, CKD Corp remains at the forefront of the industry, delivering cutting-edge products and solutions.

Who are the main competitors of CKD in the market?

The main competitors of CKD Corp in the market include companies like Hitachi Ltd, Keyence Corporation, and SMC Corporation. These companies compete with CKD Corp in the field of manufacturing and supplying industrial automation and control systems, pneumatic equipment, and various related products. With its strong presence and reputation in the market, CKD Corp faces stiff competition from these industry leaders to maintain its market share and meet customer demands.

In which industries is CKD primarily active?

CKD Corp is primarily active in the industries of manufacturing and engineering. They specialize in developing and producing a wide range of products including industrial automation equipment, pneumatic components, fluid control systems, and environmental products. CKD Corp's expertise and solutions cater to various sectors such as automotive, semiconductor, pharmaceutical, food processing, and packaging. With their strong presence and innovative solutions, CKD Corp has established itself as a leading player in the manufacturing and engineering industries, providing high-quality products and services to their clients worldwide.

What is the business model of CKD?

The business model of CKD Corp is centered around the manufacturing and sale of automation and control systems, as well as industrial machinery and equipment. With a focus on precision and quality, CKD Corp caters to a wide range of industries such as automotive, electronics, and food processing. A key aspect of their business strategy involves developing innovative solutions that enhance productivity and efficiency for their clients. By offering a comprehensive portfolio of products, CKD Corp strives to meet the specific needs of various sectors, steadily growing their presence in the global market.

What is the P/E ratio of CKD 2024?

The CKD P/E ratio is 20.86.

What is the P/S ratio of CKD 2024?

The CKD P/S ratio is 1.29.

What is the AlleAktien quality score of CKD?

The AlleAktien quality score for CKD is 7/10.

What is the revenue of CKD 2024?

The CKD revenue is 134.43 B JPY.

How high is the profit of CKD 2024?

The CKD profit is 8.34 B JPY.

What is the business model of CKD

CKD Corporation is a Japanese company that has been active in the field of machinery and automation since 1943 and is now active in various industries. The name CKD stands for "Central Glass Company Kogyo Division," as the company was initially a division of Central Glass Company. Over the years, the company has become a leading provider of components, systems, and services for the automation industry. CKD's business activities include various sectors, including fluid control systems, electromagnetic valves, and pneumatics. Fluid control systems include valves, pumps, and equipment for controlling liquids and gases in various industrial applications such as food and beverage production, chemical and pharmaceutical industries, and water treatment. Electromagnetic valves provide solutions for controlling gases and liquids and are used in the automotive industry, paper and printing industries, as well as in the production of semiconductors and flat panel displays. Pneumatic products such as cylinders, valves, air pressure pumps, and filtration systems are used in various industries, from the automotive industry to aerospace. The company also offers a range of automation systems and services. These include robots, industrial robot cells, controls, and software for automating processes and equipment in manufacturing industries. CKD also offers a wide range of products for monitoring, controlling, and regulating various parameters in the industry. These include pressure sensors, temperature sensors, flow meters, and humidity sensors. The company operates globally and has branches in Europe, North America, and Asia. CKD also has an extensive research and development department focused on the development of new technologies and products. CKD's business model is based on a consistent focus on the needs of its customers. The company is committed to developing innovative products and solutions that enable its customers to increase productivity, reduce costs, and improve their competitive position. CKD's success is based on a strong culture of innovation, high quality products, and excellent customer support. The company places special emphasis on training its employees and collaborating with its partners and suppliers. In summary, CKD is a leading provider of components, systems, and services for the automation industry. The company offers a wide range of products and solutions in the areas of fluid control systems, electromagnetic valves, pneumatics, automation, monitoring, control and regulation, as well as research and development, enabling its customers to increase productivity and improve their competitive position.

What is the CKD dividend?

CKD pays a dividend of 81 JPY distributed over payouts per year.

How often does CKD pay dividends?

The dividend cannot currently be calculated for CKD or the company does not pay out a dividend.

What is the CKD ISIN?

The ISIN of CKD is JP3346800000.

What is the CKD ticker?

The ticker of CKD is 6407.T.

How much dividend does CKD pay?

Over the past 12 months, CKD paid a dividend of 56 JPY . This corresponds to a dividend yield of about 2.15 %. For the coming 12 months, CKD is expected to pay a dividend of 59.52 JPY.

What is the dividend yield of CKD?

The current dividend yield of CKD is 2.15 %.

When does CKD pay dividends?

CKD pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of CKD?

CKD paid dividends every year for the past 23 years.

What is the dividend of CKD?

For the upcoming 12 months, dividends amounting to 59.52 JPY are expected. This corresponds to a dividend yield of 2.28 %.

In which sector is CKD located?

CKD is assigned to the 'Industry' sector.

Wann musste ich die Aktien von CKD kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CKD from 12/1/2024 amounting to 30 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did CKD pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of CKD in the year 2023?

In the year 2023, CKD distributed 71 JPY as dividends.

In which currency does CKD pay out the dividend?

The dividends of CKD are distributed in JPY.

All fundamentals about CKD

Our stock analysis for CKD Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CKD Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.